Related Experiment Videos
Prostaglandin E1 as a hypotensive drug during general anaesthesia
Anaesthesia
|May 1, 1982
Summary
Prostaglandin E1 (PGE1) safely controlled blood pressure during mastectomy anesthesia, significantly reducing blood loss. Induced hypotension was reversible, with well-maintained renal function, suggesting PGE1 is a viable option for surgical blood loss management.
Area of Science:
- Anesthesiology
- Cardiovascular Pharmacology
- Surgical Hemostasis
Background:
- Prostaglandin E1 (PGE1) is a vasodilator with potential applications in managing intraoperative hemodynamics.
- Reducing operative blood loss during mastectomy is crucial for patient outcomes.
- Controlled hypotension can minimize surgical bleeding but requires careful management.
Purpose of the Study:
- To investigate the efficacy and safety of PGE1-induced hypotension for reducing blood loss during mastectomy.
- To assess the hemodynamic and renal effects of PGE1 infusion during halothane anesthesia.
Main Methods:
- PGE1 was infused at 100-150 ng/kg/minute during halothane anesthesia in patients undergoing mastectomy.
- Systolic arterial pressure, heart rate, pre-ejection period, and left ventricular ejection period were monitored.
- Renal function and operative blood loss were assessed.
Main Results:
- PGE1 infusion decreased systolic arterial pressure by approximately 34%, with recovery within 15 minutes of cessation.
- Induced hypotension lasted about 75 minutes without significant changes in heart rate.
- Renal function remained well-maintained, and operative blood loss was significantly reduced.
Conclusions:
- PGE1 can be safely utilized to induce controlled hypotension during mastectomy under halothane anesthesia.
- PGE1 effectively reduces surgical blood loss while maintaining hemodynamic stability and renal function.
- PGE1 represents a promising agent for managing arterial pressure and minimizing bleeding in surgical settings.